Noveome Biotherapeutics, Inc. announced it raised $870,000 in an initial filing from an offering of $15 Million
Noveome Biotherapeutics, Inc. announced it raised $870,000 in an initial filing from an offering of $15 Million
10/02/20, 4:33 PM
Location
pittsburgh
Money raised
$870,000
Industry
biotechnology
Round Type
seed
Company Info
Location
100 technology drive
pittsburgh, pennsylvania, united states
Additional Info
Noveome Biotherapeutics, Inc. is a clinical stage company focused on breakthrough therapies for the regenerative repair of inflamed or damaged tissues. The company, originally founded as Stemnion, Inc., is located in the heart of Pittsburgh near the Southside Works. Noveome is passionate about growing its business in Allegheny County and helping the region to become a world leader in biotherapeutic research and development.
Noveome Biotherapeutics, Inc. is a dynamic biopharmaceutical company with an innovative platform technology that represents a paradigm shift in drug development. Unlike most drugs that are single molecules directed at specific indications, Noveome’s product is a complex mixture of biomolecules that is believed to have the ability to treat a wide range of conditions and injuries. Noveome collaborates with major research centers to advance these therapeutic applications.